Iwase H, Kobayashi S, Samoto T, Kobayashi M, Karamatsu S, Masaoka A, Kato T
Nihon Naibunpi Gakkai Zasshi. 1985 Oct 20;61(10):1147-56. doi: 10.1507/endocrine1927.61.10_1147.
It is very important to detect the intracellular distribution and dynamics of estrogen receptor (ER) in order to make the mechanisms of estrogen action clear. In a recent report, monoclonal antibodies localized ER only in the nucleus of target cells under both the presence and absence of estrogen. We purified cow and human uterine ER and induced specific polyclonal anti-ER antibodies. In this report, the specificity of immunological reactivity of anti-ER antibodies was examined, and the distribution of ER in the target tissues was detected by the indirect immunoperoxidase method. The specific staining was observed in the nucleus and cytoplasm of the endo- and myometrium of cow, rat and human uterus. In the nontarget organs, such as kidney and muscle, the specific staining was not detected. The cytoplasm of MCF-7 cells and immature rat uterine tissues were mainly stained without estrogen; however, the nuclear staining increased obviously after the estrogen priming. The cytoplasmic and/or nuclear staining was positive in 63% of 21 human breast cancer cases. This immunohistochemical assay (IHC) method of ER measurement was compared with the DCC assay method, a biochemical assay based on hormone binding ability. The concomitant positivity or negativity in DCC and IHC were observed as 61.9% (13 cases) or 19.0% (4 cases), respectively. Therefore, these two methods showed the same assay results in 81.0% of human breast cancer tissues.
为了弄清楚雌激素作用的机制,检测雌激素受体(ER)的细胞内分布和动态变化非常重要。在最近的一份报告中,单克隆抗体在有或无雌激素的情况下都仅将ER定位在靶细胞的细胞核中。我们纯化了牛和人的子宫ER,并诱导产生了特异性多克隆抗ER抗体。在本报告中,检测了抗ER抗体免疫反应性的特异性,并通过间接免疫过氧化物酶法检测了ER在靶组织中的分布。在牛、大鼠和人的子宫内膜和肌层的细胞核和细胞质中观察到特异性染色。在非靶器官,如肾脏和肌肉中,未检测到特异性染色。在没有雌激素的情况下,MCF-7细胞和未成熟大鼠子宫组织的细胞质主要被染色;然而,雌激素预处理后细胞核染色明显增加。在21例人类乳腺癌病例中,63%的病例细胞质和/或细胞核染色呈阳性。将这种检测ER的免疫组织化学分析(IHC)方法与基于激素结合能力的生化分析方法DCC进行了比较。DCC和IHC同时呈阳性或阴性的情况分别为61.9%(13例)或19.0%(4例)。因此,这两种方法在81.0%的人类乳腺癌组织中显示出相同的检测结果。